JP2024547057A5 - - Google Patents

Info

Publication number
JP2024547057A5
JP2024547057A5 JP2024536988A JP2024536988A JP2024547057A5 JP 2024547057 A5 JP2024547057 A5 JP 2024547057A5 JP 2024536988 A JP2024536988 A JP 2024536988A JP 2024536988 A JP2024536988 A JP 2024536988A JP 2024547057 A5 JP2024547057 A5 JP 2024547057A5
Authority
JP
Japan
Prior art keywords
sequence
circular rna
circular
cells
myc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024536988A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024547057A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081898 external-priority patent/WO2023122517A2/en
Publication of JP2024547057A publication Critical patent/JP2024547057A/ja
Publication of JP2024547057A5 publication Critical patent/JP2024547057A5/ja
Pending legal-status Critical Current

Links

JP2024536988A 2021-12-20 2022-12-19 環状rnaを使用した細胞の再プログラム化のための組成物及び方法 Pending JP2024547057A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163291645P 2021-12-20 2021-12-20
US63/291,645 2021-12-20
PCT/US2022/081898 WO2023122517A2 (en) 2021-12-20 2022-12-19 Compositions and methods for cellular reprogramming using circular rna

Publications (2)

Publication Number Publication Date
JP2024547057A JP2024547057A (ja) 2024-12-26
JP2024547057A5 true JP2024547057A5 (cg-RX-API-DMAC7.html) 2026-01-05

Family

ID=86903667

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536988A Pending JP2024547057A (ja) 2021-12-20 2022-12-19 環状rnaを使用した細胞の再プログラム化のための組成物及び方法

Country Status (10)

Country Link
US (1) US20240327799A1 (cg-RX-API-DMAC7.html)
EP (1) EP4453205A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024547057A (cg-RX-API-DMAC7.html)
KR (1) KR20240123826A (cg-RX-API-DMAC7.html)
CN (1) CN118574930A (cg-RX-API-DMAC7.html)
AU (1) AU2022420484A1 (cg-RX-API-DMAC7.html)
CA (1) CA3240645A1 (cg-RX-API-DMAC7.html)
IL (1) IL313604A (cg-RX-API-DMAC7.html)
TW (1) TW202330907A (cg-RX-API-DMAC7.html)
WO (1) WO2023122517A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN122477277A (zh) * 2023-11-16 2026-07-28 科洛索生物科学有限公司 用于生成诱导多能干细胞的方法和组合物
WO2025240429A1 (en) * 2024-05-13 2025-11-20 Colossal Biosciences Inc. Methods and compositions for creating elephant induced pluripotent stem cells
CN118638781B (zh) * 2024-05-27 2025-05-16 毕昇(北京)生物科技有限公司 使用环状RNA和microRNA进行细胞重编程的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8496941B2 (en) * 2009-06-03 2013-07-30 National Institute Of Advanced Industrial Science And Technology Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
WO2011032166A2 (en) * 2009-09-14 2011-03-17 The Johns Hopkins University Reprogramming blood cells to pluripotent and multipotent stem cells
AU2013266496B2 (en) * 2012-05-21 2018-08-09 The Regents Of The University Of California Generation of human iPS cells by a synthetic self- replicative RNA
CN112399860B (zh) * 2018-06-06 2024-08-16 麻省理工学院 用于在真核细胞中翻译的环状rna
JP7686574B2 (ja) * 2019-05-22 2025-06-02 マサチューセッツ インスティテュート オブ テクノロジー 環状rna組成物及び方法
JP2024516200A (ja) * 2021-04-27 2024-04-12 ファクター バイオサイエンス インコーポレイテッド 環状rna
US20230042860A1 (en) * 2021-07-15 2023-02-09 Turn Biotechnologies, Inc. Polycistronic expression vectors

Similar Documents

Publication Publication Date Title
JP7153992B2 (ja) Rna誘導性遺伝子制御および編集のための直交性cas9タンパク質
AU2019202160B2 (en) Methods and compositions for the targeted modification of a genome
JP6940117B2 (ja) オンターゲットおよびオフターゲットの多標的システムを用いた標的特異的ヌクレアーゼをスクリーニングするための方法およびその利用
ES2865275T3 (es) Células inmunocompatibles creadas por edición mediada por nucleasas, de genes que codifican HLA
JP2021094040A5 (cg-RX-API-DMAC7.html)
JP7059468B2 (ja) 多重ゲノム編集
AU2015334469B2 (en) Permanent epigenetic gene silencing
CA3228222A1 (en) Class ii, type v crispr systems
AU2022213505A1 (en) Gene silencing
JP2017517256A (ja) 遺伝子配列を編集する方法
US20250304934A1 (en) Reprogrammable fanzor polynucleotides and uses thereof
JP2011516042A (ja) 部位特異的組み換えを用いて無ベクター誘導多能性幹(iPS)細胞を作製するベクターおよびその方法
NZ732895A (en) Methods and compositions for targeted genetic modification through single-step multiple targeting
US20240318165A1 (en) Type i-b crispr-associated transposase systems
CN106834320A (zh) Tal效应子介导的dna修饰
US20240123088A1 (en) USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING
US20220298501A1 (en) Crispr-associated mu transposase systems
Schumann et al. The impact of transposable element activity on therapeutically relevant human stem cells
JP2023526007A5 (cg-RX-API-DMAC7.html)
Zhao et al. Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells
Wang et al. Measles vector as a multigene delivery platform facilitating iPSC reprogramming
JP7097050B2 (ja) 効率的な人工多能性幹細胞の樹立方法
KR20200066748A (ko) 바이러스 벡터, 세포 및 작제물
CN121889502A (zh) 长毛猛犸象特异性基因变体及包含其的组合物
AR125308A1 (es) Vectores de transferencia de genes y métodos de ingeniería celular